市场调查报告书

虫媒病毒检验的市场

Arbovirus Testing

出版商 Global Industry Analysts, Inc. 商品编码 956945
出版日期 内容资讯 英文 279 Pages
商品交期: 最快1-2个工作天内
价格
虫媒病毒检验的市场 Arbovirus Testing
出版日期: 2020年09月01日内容资讯: 英文 279 Pages
简介

全球虫媒病毒检验的市场规模在2020年~2027年的分析期间中预计将以4%的年复合成长率增长,从2020年的11亿美元到2027年达到14亿美元。市场区隔之一的ELISA (酵素结合免疫吸附法) 为基础的检验部门在分析期间结束前预测将以3.7%的年率增长,达到7亿9,980万美元的规模。

本报告提供全球虫媒病毒检验市场的相关调查,提供市场占有率,趋势和预测,成长要素,各地区的市场分析,竞争情形,主要企业的简介等资讯。

调查对象企业范例

  • Alere, Inc.
  • Diamedix Corporation
  • Euroimmun AG
  • Focus Diagnostics, Inc.
  • IBL International GmbH
  • NovaTec Immundiagnostica GmbH
  • Thermo Fisher Scientific, Inc.

目录

I. 简介,调查手法 、 调查范围

II. 摘要整理

  • 市场概要
    • 竞争的市场占有率
    • 竞争的市场占有率方案
    • Covid-19的影响和即将到来的全球景气衰退
  • 主要企业
  • 趋势与成长要素
  • 全球市场预测

III. 市场分析

  • 各地区市场分析
  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 其他中东
  • 非洲

IV. 竞争

  • 企业简介:42公司
目录
Product Code: MCP10361

Global Arbovirus Testing Market to Reach $1.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Arbovirus Testing estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at aCAGR of 4% over the period 2020-2027. ELISA-based Tests, one of the segments analyzed in the report, is projected to record 3.7% CAGR and reach US$799.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the RT-PCR based Tests segment is readjusted to a revised 4.3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $287.4 Million, While China is Forecast to Grow at 7.1% CAGR

The Arbovirus Testing market in the U.S. is estimated at US$287.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$297.6 Million by the year 2027 trailing a CAGR of 7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.3% and 3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.We bring years of research experience to this 6th edition of our report. The 279-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Alere, Inc.
  • Diamedix Corporation
  • Euroimmun AG
  • Focus Diagnostics, Inc.
  • IBL International GmbH
  • NovaTec Immundiagnostica GmbH
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Global Competitor Market Shares
    • Arbovirus Testing Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Arbovirus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 2: World Historic Review for Arbovirus Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 3: World 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
    • TABLE 4: World Current & Future Analysis for ELISA-based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 5: World Historic Review for ELISA-based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 6: World 15-Year Perspective for ELISA-based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 7: World Current & Future Analysis for RT-PCR based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 8: World Historic Review for RT-PCR based Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 9: World 15-Year Perspective for RT-PCR based Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 10: World Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 12: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 14: World Historic Review for Public Health Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 15: World 15-Year Perspective for Public Health Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 16: World Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 17: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 18: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
    • TABLE 19: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 21: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Arbovirus Testing Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 22: USA Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 23: USA Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 24: USA 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 25: USA Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 26: USA Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 27: USA 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • CANADA
    • TABLE 28: Canada Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 29: Canada Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 30: Canada 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 31: Canada Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 32: Canada Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 33: Canada 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • JAPAN
    • TABLE 34: Japan Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 35: Japan Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 36: Japan 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 37: Japan Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 38: Japan Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 39: Japan 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • CHINA
    • TABLE 40: China Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 41: China Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 42: China 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 43: China Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 44: China Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 45: China 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • EUROPE
    • Market Facts & Figures
    • European Arbovirus Testing Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 46: Europe Current & Future Analysis for Arbovirus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 47: Europe Historic Review for Arbovirus Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 48: Europe 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
    • TABLE 49: Europe Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 50: Europe Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 51: Europe 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 52: Europe Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 53: Europe Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 54: Europe 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • FRANCE
    • TABLE 55: France Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 56: France Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 57: France 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 58: France Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 59: France Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 60: France 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • GERMANY
    • TABLE 61: Germany Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 62: Germany Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 63: Germany 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 64: Germany Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 65: Germany Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 66: Germany 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ITALY
    • TABLE 67: Italy Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 68: Italy Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 69: Italy 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 70: Italy Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 71: Italy Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 72: Italy 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED KINGDOM
    • TABLE 73: UK Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 74: UK Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 75: UK 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 76: UK Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 77: UK Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 78: UK 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SPAIN
    • TABLE 79: Spain Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 80: Spain Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 81: Spain 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 82: Spain Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 83: Spain Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 84: Spain 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • RUSSIA
    • TABLE 85: Russia Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 86: Russia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 87: Russia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 88: Russia Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 89: Russia Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 90: Russia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF EUROPE
    • TABLE 91: Rest of Europe Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 92: Rest of Europe Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 93: Rest of Europe 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 94: Rest of Europe Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 95: Rest of Europe Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 96: Rest of Europe 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 97: Asia-Pacific Current & Future Analysis for Arbovirus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 98: Asia-Pacific Historic Review for Arbovirus Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 99: Asia-Pacific 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
    • TABLE 100: Asia-Pacific Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 101: Asia-Pacific Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 102: Asia-Pacific 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 103: Asia-Pacific Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 104: Asia-Pacific Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 105: Asia-Pacific 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • AUSTRALIA
    • TABLE 106: Australia Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 107: Australia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 108: Australia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 109: Australia Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 110: Australia Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 111: Australia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • INDIA
    • TABLE 112: India Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 113: India Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 114: India 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 115: India Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 116: India Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 117: India 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SOUTH KOREA
    • TABLE 118: South Korea Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 119: South Korea Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 120: South Korea 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 121: South Korea Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 122: South Korea Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 123: South Korea 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 125: Rest of Asia-Pacific Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 126: Rest of Asia-Pacific 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 127: Rest of Asia-Pacific Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 128: Rest of Asia-Pacific Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 129: Rest of Asia-Pacific 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • LATIN AMERICA
    • TABLE 130: Latin America Current & Future Analysis for Arbovirus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 131: Latin America Historic Review for Arbovirus Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 132: Latin America 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
    • TABLE 133: Latin America Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 134: Latin America Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 135: Latin America 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 136: Latin America Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 137: Latin America Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 138: Latin America 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ARGENTINA
    • TABLE 139: Argentina Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 140: Argentina Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 141: Argentina 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 142: Argentina Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 143: Argentina Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 144: Argentina 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • BRAZIL
    • TABLE 145: Brazil Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 146: Brazil Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 147: Brazil 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 148: Brazil Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 149: Brazil Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 150: Brazil 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • MEXICO
    • TABLE 151: Mexico Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 152: Mexico Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 153: Mexico 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 154: Mexico Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 155: Mexico Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 156: Mexico 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF LATIN AMERICA
    • TABLE 157: Rest of Latin America Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 158: Rest of Latin America Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 159: Rest of Latin America 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 160: Rest of Latin America Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 161: Rest of Latin America Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 162: Rest of Latin America 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • MIDDLE EAST
    • TABLE 163: Middle East Current & Future Analysis for Arbovirus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through
    • TABLE 164: Middle East Historic Review for Arbovirus Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 165: Middle East 15-Year Perspective for Arbovirus Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
    • TABLE 166: Middle East Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 167: Middle East Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 168: Middle East 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 169: Middle East Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 170: Middle East Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 171: Middle East 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • IRAN
    • TABLE 172: Iran Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 173: Iran Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 174: Iran 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 175: Iran Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 176: Iran Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 177: Iran 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • ISRAEL
    • TABLE 178: Israel Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 179: Israel Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 180: Israel 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 181: Israel Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 182: Israel Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 183: Israel 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • SAUDI ARABIA
    • TABLE 184: Saudi Arabia Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 185: Saudi Arabia Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 186: Saudi Arabia 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 187: Saudi Arabia Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 188: Saudi Arabia Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 189: Saudi Arabia 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • UNITED ARAB EMIRATES
    • TABLE 190: UAE Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 191: UAE Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 192: UAE 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 193: UAE Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 194: UAE Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 195: UAE 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • REST OF MIDDLE EAST
    • TABLE 196: Rest of Middle East Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 197: Rest of Middle East Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 198: Rest of Middle East 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 199: Rest of Middle East Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 200: Rest of Middle East Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 201: Rest of Middle East 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027
  • AFRICA
    • TABLE 202: Africa Current & Future Analysis for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 203: Africa Historic Review for Arbovirus Testing by Test Type - ELISA-based Tests and RT-PCR based Tests Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 204: Africa 15-Year Perspective for Arbovirus Testing by Test Type - Percentage Breakdown of Value Sales for ELISA-based Tests and RT-PCR based Tests for the Years 2012, 2020 & 2027
    • TABLE 205: Africa Current & Future Analysis for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through
    • TABLE 206: Africa Historic Review for Arbovirus Testing by End-Use - Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through
    • TABLE 207: Africa 15-Year Perspective for Arbovirus Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Public Health Laboratory, Diagnostic Centers and Other End-Uses for the Years 2012, 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 42